Does the media favor AJG or RYAN?

In the previous week, Arthur J. Gallagher & Co. had 6 more articles in the media than Ryan Specialty. MarketBeat recorded 31 mentions for Arthur J. Gallagher & Co. and 25 mentions for Ryan Specialty. Arthur J. Gallagher & Co.'s average media sentiment score of 0.84 beat Ryan Specialty's score of 0.54 indicating that Arthur J. Gallagher & Co. is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arthur J. Gallagher & Co. 12 Very Positive mention(s) 7 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ryan Specialty 8 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BRO or RYAN?

In the previous week, Ryan Specialty had 1 more articles in the media than Brown & Brown. MarketBeat recorded 25 mentions for Ryan Specialty and 24 mentions for Brown & Brown. Brown & Brown's average media sentiment score of 0.59 beat Ryan Specialty's score of 0.54 indicating that Brown & Brown is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brown & Brown 8 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Ryan Specialty 8 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to RYAN or SLF?

In the previous week, Ryan Specialty had 21 more articles in the media than Sun Life Financial. MarketBeat recorded 25 mentions for Ryan Specialty and 4 mentions for Sun Life Financial. Sun Life Financial's average media sentiment score of 0.67 beat Ryan Specialty's score of 0.54 indicating that Sun Life Financial is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ryan Specialty 8 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Sun Life Financial 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend RYAN or PUK?

Ryan Specialty presently has a consensus target price of $48.35, indicating a potential upside of 15.76%. Given Ryan Specialty's higher probable upside, research analysts plainly believe Ryan Specialty is more favorable than Prudential Public. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ryan Specialty 2 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.32 Prudential Public 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.86

Which has higher valuation and earnings, RYAN or PUK?

Prudential Public has higher revenue and earnings than Ryan Specialty. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ryan Specialty $3.05B 3.61 $63.40M $0.77 54.25 Prudential Public $27.76B 1.29 $3.98B N/A N/A

Does the media refer more to RYAN or WTW?

In the previous week, Willis Towers Watson Public had 13 more articles in the media than Ryan Specialty. MarketBeat recorded 38 mentions for Willis Towers Watson Public and 25 mentions for Ryan Specialty. Willis Towers Watson Public's average media sentiment score of 0.78 beat Ryan Specialty's score of 0.54 indicating that Willis Towers Watson Public is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ryan Specialty 8 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Willis Towers Watson Public 9 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Ryan Specialty (RYAN) Competitors

$41.77 +1.36 (+3.36%)

Closing price 03:59 PM Eastern

Extended Trading

$41.77 +0.00 (+0.00%)

As of 06:18 PM Eastern

Compare

RYAN vs. AJG, BRO, SLF, PUK, and WTW

Should you buy Ryan Specialty stock or one of its competitors? MarketBeat compares Ryan Specialty with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Ryan Specialty include Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), Sun Life Financial (SLF), Prudential Public (PUK), and Willis Towers Watson Public (WTW). These companies are all part of the "finance" sector.

How does Ryan Specialty compare to Arthur J. Gallagher & Co.?

Arthur J. Gallagher & Co. (NYSE:AJG) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

In the previous week, Arthur J. Gallagher & Co. had 6 more articles in the media than Ryan Specialty. MarketBeat recorded 31 mentions for Arthur J. Gallagher & Co. and 25 mentions for Ryan Specialty. Arthur J. Gallagher & Co.'s average media sentiment score of 0.84 beat Ryan Specialty's score of 0.54 indicating that Arthur J. Gallagher & Co. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Arthur J. Gallagher & Co.	12 Very Positive mention(s)	7 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ryan Specialty	8 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Arthur J. Gallagher & Co. presently has a consensus target price of $276.53, suggesting a potential upside of 5.97%. Ryan Specialty has a consensus target price of $48.35, suggesting a potential upside of 15.76%. Given Ryan Specialty's higher possible upside, analysts clearly believe Ryan Specialty is more favorable than Arthur J. Gallagher & Co..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arthur J. Gallagher & Co.	0 Sell rating(s)	7 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.63
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32

Arthur J. Gallagher & Co. has higher revenue and earnings than Ryan Specialty. Arthur J. Gallagher & Co. is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arthur J. Gallagher & Co.	$13.94B	4.81	$1.49B	$6.18	42.23
Ryan Specialty	$3.05B	3.61	$63.40M	$0.77	54.25

85.5% of Arthur J. Gallagher & Co. shares are owned by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are owned by institutional investors. 1.4% of Arthur J. Gallagher & Co. shares are owned by insiders. Comparatively, 52.0% of Ryan Specialty shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Arthur J. Gallagher & Co. has a net margin of 10.76% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Arthur J. Gallagher & Co.'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arthur J. Gallagher & Co.	10.76%	12.83%	3.89%
Ryan Specialty	8.21%	41.33%	4.80%

Arthur J. Gallagher & Co. has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Arthur J. Gallagher & Co. pays an annual dividend of $2.80 per share and has a dividend yield of 1.1%. Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Arthur J. Gallagher & Co. pays out 45.3% of its earnings in the form of a dividend. Ryan Specialty pays out 67.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Arthur J. Gallagher & Co. has raised its dividend for 15 consecutive years and Ryan Specialty has raised its dividend for 1 consecutive years.

Summary

Arthur J. Gallagher & Co. beats Ryan Specialty on 12 of the 19 factors compared between the two stocks.

How does Ryan Specialty compare to Brown & Brown?

Brown & Brown (NYSE:BRO) and Ryan Specialty (NYSE:RYAN) are both large-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Brown & Brown pays an annual dividend of $0.66 per share and has a dividend yield of 1.0%. Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Brown & Brown pays out 21.2% of its earnings in the form of a dividend. Ryan Specialty pays out 67.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has raised its dividend for 1 consecutive years. Ryan Specialty is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Brown & Brown has higher revenue and earnings than Ryan Specialty. Brown & Brown is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brown & Brown	$5.90B	3.98	$1.05B	$3.11	22.27
Ryan Specialty	$3.05B	3.61	$63.40M	$0.77	54.25

Brown & Brown presently has a consensus price target of $78.63, indicating a potential upside of 13.54%. Ryan Specialty has a consensus price target of $48.35, indicating a potential upside of 15.76%. Given Ryan Specialty's stronger consensus rating and higher probable upside, analysts clearly believe Ryan Specialty is more favorable than Brown & Brown.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brown & Brown	2 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.16
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32

In the previous week, Ryan Specialty had 1 more articles in the media than Brown & Brown. MarketBeat recorded 25 mentions for Ryan Specialty and 24 mentions for Brown & Brown. Brown & Brown's average media sentiment score of 0.59 beat Ryan Specialty's score of 0.54 indicating that Brown & Brown is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Brown & Brown	8 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Ryan Specialty	8 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Brown & Brown has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, Ryan Specialty has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

Brown & Brown has a net margin of 17.94% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Brown & Brown's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Brown & Brown	17.94%	12.94%	5.55%
Ryan Specialty	8.21%	41.33%	4.80%

71.0% of Brown & Brown shares are owned by institutional investors. Comparatively, 84.8% of Ryan Specialty shares are owned by institutional investors. 13.1% of Brown & Brown shares are owned by company insiders. Comparatively, 52.0% of Ryan Specialty shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Ryan Specialty beats Brown & Brown on 11 of the 19 factors compared between the two stocks.

How does Ryan Specialty compare to Sun Life Financial?

Ryan Specialty (NYSE:RYAN) and Sun Life Financial (NYSE:SLF) are both large-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

Ryan Specialty has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Sun Life Financial has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

In the previous week, Ryan Specialty had 21 more articles in the media than Sun Life Financial. MarketBeat recorded 25 mentions for Ryan Specialty and 4 mentions for Sun Life Financial. Sun Life Financial's average media sentiment score of 0.67 beat Ryan Specialty's score of 0.54 indicating that Sun Life Financial is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ryan Specialty	8 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Sun Life Financial	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sun Life Financial has higher revenue and earnings than Ryan Specialty. Sun Life Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$3.05B	3.61	$63.40M	$0.77	54.25
Sun Life Financial	$29.99B	1.46	$2.68B	$3.88	20.21

Ryan Specialty has a net margin of 8.21% compared to Sun Life Financial's net margin of 7.85%. Ryan Specialty's return on equity of 41.33% beat Sun Life Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	8.21%	41.33%	4.80%
Sun Life Financial	7.85%	17.80%	1.09%

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Sun Life Financial pays an annual dividend of $2.83 per share and has a dividend yield of 3.6%. Ryan Specialty pays out 67.5% of its earnings in the form of a dividend. Sun Life Financial pays out 72.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has raised its dividend for 1 consecutive years and Sun Life Financial has raised its dividend for 11 consecutive years. Sun Life Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 52.3% of Sun Life Financial shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Ryan Specialty presently has a consensus target price of $48.35, suggesting a potential upside of 15.76%. Sun Life Financial has a consensus target price of $84.67, suggesting a potential upside of 8.00%. Given Ryan Specialty's higher possible upside, research analysts clearly believe Ryan Specialty is more favorable than Sun Life Financial.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32
Sun Life Financial	1 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Ryan Specialty beats Sun Life Financial on 11 of the 20 factors compared between the two stocks.

How does Ryan Specialty compare to Prudential Public?

Ryan Specialty (NYSE:RYAN) and Prudential Public (NYSE:PUK) are both large-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Prudential Public has higher revenue and earnings than Ryan Specialty.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$3.05B	3.61	$63.40M	$0.77	54.25
Prudential Public	$27.76B	1.29	$3.98B	N/A	N/A

84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 1.9% of Prudential Public shares are owned by institutional investors. 52.0% of Ryan Specialty shares are owned by company insiders. Comparatively, 0.1% of Prudential Public shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Ryan Specialty had 24 more articles in the media than Prudential Public. MarketBeat recorded 25 mentions for Ryan Specialty and 1 mentions for Prudential Public. Prudential Public's average media sentiment score of 1.00 beat Ryan Specialty's score of 0.54 indicating that Prudential Public is being referred to more favorably in the news media.

Company	Overall Sentiment
Ryan Specialty	Positive
Prudential Public	Positive

Ryan Specialty has a net margin of 8.21% compared to Prudential Public's net margin of 0.00%. Ryan Specialty's return on equity of 41.33% beat Prudential Public's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	8.21%	41.33%	4.80%
Prudential Public	N/A	N/A	N/A

Ryan Specialty presently has a consensus target price of $48.35, indicating a potential upside of 15.76%. Given Ryan Specialty's higher probable upside, research analysts plainly believe Ryan Specialty is more favorable than Prudential Public.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32
Prudential Public	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Ryan Specialty has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Prudential Public has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Prudential Public pays an annual dividend of $0.72 per share and has a dividend yield of 2.5%. Ryan Specialty pays out 67.5% of its earnings in the form of a dividend. Ryan Specialty has raised its dividend for 1 consecutive years.

Summary

Ryan Specialty beats Prudential Public on 10 of the 18 factors compared between the two stocks.

How does Ryan Specialty compare to Willis Towers Watson Public?

Ryan Specialty (NYSE:RYAN) and Willis Towers Watson Public (NASDAQ:WTW) are both large-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Willis Towers Watson Public has higher revenue and earnings than Ryan Specialty. Willis Towers Watson Public is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$3.05B	3.61	$63.40M	$0.77	54.25
Willis Towers Watson Public	$9.71B	2.88	$1.61B	$17.15	17.23

Willis Towers Watson Public has a net margin of 16.84% compared to Ryan Specialty's net margin of 8.21%. Ryan Specialty's return on equity of 41.33% beat Willis Towers Watson Public's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	8.21%	41.33%	4.80%
Willis Towers Watson Public	16.84%	21.52%	6.00%

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 93.1% of Willis Towers Watson Public shares are held by institutional investors. 52.0% of Ryan Specialty shares are held by insiders. Comparatively, 0.4% of Willis Towers Watson Public shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Ryan Specialty has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, Willis Towers Watson Public has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

In the previous week, Willis Towers Watson Public had 13 more articles in the media than Ryan Specialty. MarketBeat recorded 38 mentions for Willis Towers Watson Public and 25 mentions for Ryan Specialty. Willis Towers Watson Public's average media sentiment score of 0.78 beat Ryan Specialty's score of 0.54 indicating that Willis Towers Watson Public is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ryan Specialty	8 Very Positive mention(s)	5 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Willis Towers Watson Public	9 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Ryan Specialty pays an annual dividend of $0.52 per share and has a dividend yield of 1.2%. Willis Towers Watson Public pays an annual dividend of $3.84 per share and has a dividend yield of 1.3%. Ryan Specialty pays out 67.5% of its earnings in the form of a dividend. Willis Towers Watson Public pays out 22.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ryan Specialty has increased its dividend for 1 consecutive years and Willis Towers Watson Public has increased its dividend for 8 consecutive years. Willis Towers Watson Public is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Ryan Specialty currently has a consensus price target of $48.35, indicating a potential upside of 15.76%. Willis Towers Watson Public has a consensus price target of $349.53, indicating a potential upside of 18.27%. Given Willis Towers Watson Public's stronger consensus rating and higher possible upside, analysts clearly believe Willis Towers Watson Public is more favorable than Ryan Specialty.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	2 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.32
Willis Towers Watson Public	0 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.76

Summary

Willis Towers Watson Public beats Ryan Specialty on 15 of the 20 factors compared between the two stocks.

Get Ryan Specialty News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RYAN vs. The Competition

Export

Metric	Ryan Specialty	INS Industry	Finance Sector	NYSE Exchange
Market Cap	$10.65B	$22.56B	$14.26B	$23.46B
Dividend Yield	1.29%	1.67%	5.70%	4.02%
P/E Ratio	54.25	21.71	20.48	31.06
Price / Sales	3.61	101.23	44.40	19.77
Price / Cash	12.52	12.38	19.34	18.64
Price / Book	8.79	3.18	2.25	4.77
Net Income	$63.40M	$1.06B	$1.13B	$1.06B
7 Day Performance	1.28%	1.45%	-0.76%	-0.56%
1 Month Performance	17.21%	10.32%	0.61%	-0.11%
1 Year Performance	-34.57%	-17.95%	12.27%	16.64%

Ryan Specialty Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RYAN Ryan Specialty	4.7403 of 5 stars	$41.77 +3.4%	$48.35 +15.8%	-36.7%	$10.65B	$3.05B	54.25	6,110	Analyst Forecast
AJG Arthur J. Gallagher & Co.	4.432 of 5 stars	$249.98 -1.0%	$265.00 +6.0%	-18.7%	$64.85B	$13.94B	40.45	72,000	Analyst Forecast
BRO Brown & Brown	3.8034 of 5 stars	$68.42 -2.3%	$77.94 +13.9%	-36.6%	$23.73B	$5.90B	22.00	7,905	Analyst Forecast
SLF Sun Life Financial	3.8932 of 5 stars	$78.99 -0.8%	$84.67 +7.2%	+28.7%	$44.15B	$29.99B	20.36	32,151	Analyst Forecast
PUK Prudential Public	3.8408 of 5 stars	$28.12 +2.0%	N/A	+13.8%	$34.73B	$27.76B	N/A	15,338	News Coverage Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RYAN) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ryan Specialty (RYAN) Competitors

RYAN vs. AJG, BRO, SLF, PUK, and WTW

How does Ryan Specialty compare to Arthur J. Gallagher & Co.?

Summary

How does Ryan Specialty compare to Brown & Brown?

Summary

How does Ryan Specialty compare to Sun Life Financial?

Summary

How does Ryan Specialty compare to Prudential Public?

Summary

How does Ryan Specialty compare to Willis Towers Watson Public?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RYAN vs. The Competition

Ryan Specialty Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ryan Specialty (RYAN) Competitors

RYAN vs. AJG, BRO, SLF, PUK, and WTW

How does Ryan Specialty compare to Arthur J. Gallagher & Co.?

Does the media favor AJG or RYAN?

Do analysts recommend AJG or RYAN?

Which has better earnings and valuation, AJG or RYAN?

Do institutionals & insiders have more ownership in AJG or RYAN?

Is AJG or RYAN more profitable?

Which has more risk & volatility, AJG or RYAN?

Is AJG or RYAN a better dividend stock?

Summary

How does Ryan Specialty compare to Brown & Brown?

Is BRO or RYAN a better dividend stock?

Which has better earnings and valuation, BRO or RYAN?

Do analysts prefer BRO or RYAN?

Does the media favor BRO or RYAN?

Which has more risk and volatility, BRO or RYAN?

Is BRO or RYAN more profitable?

Do institutionals and insiders believe in BRO or RYAN?

Summary

How does Ryan Specialty compare to Sun Life Financial?

Which has more volatility & risk, RYAN or SLF?

Does the media refer more to RYAN or SLF?

Which has preferable earnings & valuation, RYAN or SLF?

Is RYAN or SLF more profitable?

Is RYAN or SLF a better dividend stock?

Do institutionals and insiders hold more shares of RYAN or SLF?

Do analysts prefer RYAN or SLF?

Summary

How does Ryan Specialty compare to Prudential Public?

Which has higher valuation and earnings, RYAN or PUK?

Do institutionals and insiders believe in RYAN or PUK?

Does the media favor RYAN or PUK?

Is RYAN or PUK more profitable?

Do analysts recommend RYAN or PUK?

Which has more volatility and risk, RYAN or PUK?

Is RYAN or PUK a better dividend stock?

Summary

How does Ryan Specialty compare to Willis Towers Watson Public?

Which has better earnings and valuation, RYAN or WTW?

Is RYAN or WTW more profitable?

Do insiders and institutionals hold more shares of RYAN or WTW?

Which has more volatility and risk, RYAN or WTW?

Does the media refer more to RYAN or WTW?

Is RYAN or WTW a better dividend stock?

Do analysts recommend RYAN or WTW?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RYAN vs. The Competition

Ryan Specialty Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools